The PBAC has recommended increasing the PBS restriction level to Authority Required (Streamlined) for ICS/LABA inhalers in COPD and removing the current restrictions to stabilise patients on individual monotherapy inhalers before commencing a LAMA/LABA combination. The recommendations follow the yet to be published Post-market Review of Chronic Obstructive Pulmonary Disease (COPD) Medicines, reinforce COPD-X guidelines and ...
PBS restrictions on COPD meds a nudge towards best practice
By Mardi Chapman
19 Oct 2017